Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
07/2003
07/03/2003US20030124671 Somatomedins; kringle domains; antitumor agents; antiproliferative agents
07/03/2003US20030124670 Analgesics; antinociceptive agents; antiinflammatory agents; antidiabbetic agents; diagnosing pain disorders
07/03/2003US20030124669 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
07/03/2003US20030124667 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/03/2003US20030124666 Membrane proteins; antiproliferative agents; antitumor agents; antisense agents; neovascularization
07/03/2003US20030124665 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/03/2003US20030124663 Membrane proteins; antiproliferative agents; antitumor agents; antisense agents; neovascularization
07/03/2003US20030124662 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/03/2003US20030124661 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/03/2003US20030124660 Bak promoter expression system
07/03/2003US20030124657 Polyvalent cation-sensing receptor in atlantic salmon
07/03/2003US20030124655 Receptor protein specifically recognizing bacterial dna
07/03/2003US20030124649 Membrane associated proteins
07/03/2003US20030124644 Antibiotic production
07/03/2003US20030124634 Novel proteins involved in the synthesis and assembly of O-antigen in pseudomonas aeruginosa
07/03/2003US20030124632 Diagnostic methods
07/03/2003US20030124630 Monitoring monoclonal antibody reactivity to glycosylated fungal proteins; fungicides; immunoassays
07/03/2003US20030124625 Novel interleukin-1 receptor intracellular ligand proteins and inhibitors of ligand binding
07/03/2003US20030124614 Novel T-cell membrane protein (TIRC7), peptides and antibodies derived therefrom and uses thereof
07/03/2003US20030124613 Epitope testing using soluble HLA
07/03/2003US20030124609 Ankyrin repeat domain 2 protein variant
07/03/2003US20030124603 Exocrine gland tight junction-constituting protein jeap family
07/03/2003US20030124602 Tumour suppresor and uses thereof
07/03/2003US20030124598 PGC-1beta, a novel PGC-1 homologue and uses therefor
07/03/2003US20030124597 Compositions and methods for identifying agents which regulate autolytic processes in bacteria
07/03/2003US20030124593 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943
07/03/2003US20030124585 Peptide comprising a portion of exon; use in contraception
07/03/2003US20030124582 Polypeptide encoded by a polynucleotide of given sequence; detecting the effect of a test compound on the production of mRNA; use in identifying agonists/antagonists that may be useful in therapy
07/03/2003US20030124579 Contacting nucleic acids from a patient with a polynucleotide; hybridization; expression vectors
07/03/2003US20030124575 Dendritic cells; antigen presenting cells; g-protein coupled receptors; immunotherapy; antiinflammatory agents; antitumor agents; viricides; drug screening
07/03/2003US20030124573 Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides
07/03/2003US20030124571 Novel human septin and uses therefor
07/03/2003US20030124569 Secretory molecules
07/03/2003US20030124568 Rectifying potassium channels (kirs); neuroprotectants; ribozymes; antisense therapy; gene therapy
07/03/2003US20030124567 Use of a leptospire protein preventing and/or diagnosing and/or treating animal or human leptospirosis
07/03/2003US20030124558 Monitoring gestation in humans; in vitro fertilization and embryo transfer; progestins; immunohistochemistry
07/03/2003US20030124557 Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function
07/03/2003US20030124554 Screening method for compounds capable of modularing egr-1-regulated expression
07/03/2003US20030124551 Agents implicated in endometriosis
07/03/2003US20030124546 Fragments of nucleic acids specific to mycobacteria which are members of the M. tuberculosis complex and their applications for the detection and the differential diagnosis of members of the M. tuberculosis complex
07/03/2003US20030124543 Tumor diagnosis; anticarcinogenic agents; animal models
07/03/2003US20030124534 Measuring expression of nucleotide sequences in cells
07/03/2003US20030124531 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/03/2003US20030124530 Sequence-directed DNA-binding molecules compositons and methods
07/03/2003US20030124520 Methods for identifying agents that cause a lethal phenotype, and agents thereof
07/03/2003US20030124517 Hepatitis A virus nucleotide sequences, recombinant proteins and uses thereof
07/03/2003US20030124510 Protein whose genome contains a region which is homologous to DNA restriction enzyme present in plasmid of escherichia coli; immunologically reactive; use in diagnostics and vaccines
07/03/2003US20030124508 Method for testing the hormonal effect of substances
07/03/2003US20030124239 Water soluble animal muscle protein product
07/03/2003US20030124169 Biocompatible, biodegradable matrix and a protein, produced by expression of recombinant DNA capable of inducing endochondral bone formation in association with said matrix
07/03/2003US20030124147 Fusion toxin comprising the toxin domain of diphtheria toxin and a urokinase-type plasminogen activator domain; killing tumor cells, especially glioblastoma cells
07/03/2003US20030124146 Recombinant Rhabdoviruses as live-viral vaccines
07/03/2003US20030124145 Avian polynucleotide vaccine formula
07/03/2003US20030124144 Chimeric capsid proteins and uses thereof
07/03/2003US20030124142 Immunomodulatory constructs and their uses
07/03/2003US20030124141 Helicobacter polypeptides and corresponding polynucleotide molecules
07/03/2003US20030124140 Ovarian tumor polypeptides, polynucleotides that encode them, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells
07/03/2003US20030124138 Endogenous activating ligand which is a potentially important neuroregulator.
07/03/2003US20030124137 For use in combatting a parasitic infestation of helminths; preferably of Fasciola or Dicrocoelium origin
07/03/2003US20030124135 Recombinant intracellular pathogen vaccines and methods for use
07/03/2003US20030124133 Polypeptide having a first domain with carbohydrate binding activity and a second domain with kinase activity; tumor immunotherapy
07/03/2003US20030124124 ES-2 polypeptide encoding nucleic acid cloned from Schistosoma mansoni and shown to bind and inhibit chemokine function, including CC chemokines such as MIP-1 alpha and/or RANTES
07/03/2003US20030124116 Antibodies binding to polypeptides encoded by the genes
07/03/2003US20030124115 A carboxy terminal peptide fragment of thrombopoietin is fused with the carboxy terminal of human erythropoietin; highly enhanced in vivo half-life due to increased carbohydrate content; no antigenicity
07/03/2003US20030124114 Genes that encode cell surface molecules with conserved IgV and mucin domains; diagnosis or staging of cancer; treatment of an immunological disorder; detecting a predisposition to asthma
07/03/2003US20030124113 Human apoptosis associated proteins
07/03/2003US20030124111 Antimicrobial agent
07/03/2003US20030124108 Useful in wound healing, autoimmune disorders and inflammatory diseases
07/03/2003US20030124105 Programmed cell death genes and proteins
07/03/2003US20030124103 Tumor cells with increased immunogenicity and uses therefor
07/03/2003US20030124102 Differentiating adult pluripotent stem cells to produce myoblasts
07/03/2003US20030124100 Includes an endothelial specific enhancer element; especially modifications of the PPE promoter, which enhance its expression in response to hypoxia and angiogenesis.
07/03/2003US20030124096 DNA virus, which replicates via an RNA intermediate,that comprises a nucleotide mutation in a gene encoding a DNA polymerase or part thereof; particularly hepatitis B variants
07/03/2003US20030124094 Increasing or maintaining the blood supply in the penis
07/03/2003US20030124092 IL-17 like molecules and uses thereoflike molecules and uses thereof
07/03/2003US20030124090 Modulation of the polyvalent cation sensing receptor in the olfactory apparatus, and then exposing the fish with the same odorant after transfer to seawater or freshwater; attracting and repelling fish by modulating the expression of PVCR
07/03/2003US20030124060 Purified linear epitopes from cashew nuts, nucleic acids encoding therefor, and associated methods
07/03/2003CA2486689A1 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases
07/03/2003CA2477563A1 Probe for mass spectrometry
07/03/2003CA2476755A1 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
07/03/2003CA2471465A1 Novel g-protein coupled receptors
07/03/2003CA2471375A1 Chitin oligosaccharide elicitor-and gibberellin-responsive genes in plants, and uses thereof
07/03/2003CA2471373A1 Modified tridegins, their preparation and their use as transglutaminase inhibitors
07/03/2003CA2471371A1 Methods for identifying gibberellin responsive genes using cultured plant cells
07/03/2003CA2471198A1 Identification of novel polymorphic sites in the human mglur8 gene and uses thereof
07/03/2003CA2471181A1 Fluorescent proteins
07/03/2003CA2471160A1 Seminal vesicle tissue-specific promoters and uses thereof
07/03/2003CA2471136A1 Mono-and dual chemokine/cytokine constructs
07/03/2003CA2471110A1 Peptides for treatment of the human papillomavirus(hpv)-associated cancer and other epithelial tumors
07/03/2003CA2470900A1 Compositions and methods for the diagnosis and treatment of tumor
07/03/2003CA2470844A1 Novel compositions and methods for cancer
07/03/2003CA2470776A1 Malleable protein matrix and uses thereof
07/03/2003CA2470594A1 Leptin proteins
07/03/2003CA2470325A1 Polymorphisms of the octn1 and octn2 cation transporters associated with inflammatory bowel disease
07/03/2003CA2470178A1 Mammalian simp protein, gene sequence and uses thereof in cancer therapy
07/03/2003CA2470171A1 Modular peptide-based reagent
07/03/2003CA2470063A1 Parmaceutical agents and methods for tissue and vascular regeneration
07/03/2003CA2470031A1 Systems and methods for treating patients with collagen-rich material extracted from adipose tissue
07/03/2003CA2469972A1 Bone polypeptide-1
07/03/2003CA2469941A1 Novel nucleic acids and polypeptides